Manikkam Suthanthiran

Manikkam Suthanthiran's AcademicInfluence.com Rankings

Philosophy

#9068

World Rank

#12569

Historical Rank

Logic

#6064

World Rank

#7545

Historical Rank

philosophy Degrees

Manikkam Suthanthiran

Biology

#12403

World Rank

#15876

Historical Rank

Immunology

#825

World Rank

#848

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Manikkam Suthanthiran's Degrees

PhD Immunology University of California, San Francisco

Why Is Manikkam Suthanthiran Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Manikkam Suthanthiran's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cyclosporine induces cancer progression by a cell-autonomous mechanism (1999) (1108)
HLA-mismatched renal transplantation without maintenance immunosuppression. (2008) (908)
Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations (2005) (897)
Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (2010) (751)
Identification of a B cell signature associated with renal transplant tolerance in humans. (2010) (640)
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. (2001) (587)
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. (2005) (437)
Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. (1990) (364)
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice (2007) (342)
MicroRNA expression profiles predictive of human renal allograft status (2009) (330)
Medical progress : renal transplantation (1994) (278)
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells (2007) (252)
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. (2013) (251)
Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage (2000) (249)
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1 (2002) (245)
Tacrolimus enhances transforming growth factor-&bgr;1 expression and promotes tumor progression (2003) (233)
Rapamycin is an effective inhibitor of human renal cancer metastasis. (2003) (209)
Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction (1991) (195)
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins (1991) (194)
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. (2004) (180)
Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy (1996) (178)
In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine. (1998) (178)
Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. (1996) (148)
Cyclosporine-induced remission of relapsing nephrotic syndrome in children. (1988) (147)
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells (1990) (143)
Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. (1994) (140)
TGF-β1 DNA Polymorphisms, Protein Levels, and Blood Pressure (1999) (140)
MicroRNAs: Small RNAs With Big Effects (2010) (137)
Immunosuppressants: cellular and molecular mechanisms of action. (1996) (137)
Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. (2000) (128)
Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study (2014) (126)
Advanced glycosylation endproduct-specific receptors on human and rat T- lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling (1993) (123)
Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation (2015) (121)
The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research (2019) (120)
Renal transplantation. (1994) (119)
Hydroxyl radical scavengers inhibit human natural killer cell activity (1984) (119)
In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine. (1997) (117)
Transforming growth factor beta and progression of renal disease. (2003) (117)
Independent Risk Factors for Urinary Tract Infection and for Subsequent Bacteremia or Acute Cellular Rejection: A Single-Center Report of 1166 Kidney Allograft Recipients (2013) (116)
Angiogenic Factors in Superimposed Preeclampsia: A Longitudinal Study of Women With Chronic Hypertension During Pregnancy (2012) (116)
Gut Microbial Community Structure and Complications After Kidney Transplantation: A Pilot Study (2014) (116)
Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center. (1985) (116)
Epidemiology of BK Virus in Renal Allograft Recipients: Independent Risk Factors for BK Virus Replication (2008) (113)
Stimulation of transforming growth factor‐β 1 transcription by cyclosporine (1995) (111)
ENHANCED GRANULYSIN mRNA EXPRESSION IN URINARY SEDIMENT IN EARLY AND DELAYED ACUTE RENAL ALLOGRAFT REJECTION (2004) (107)
Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer (2004) (107)
MicroRNA Sequence Profiles of Human Kidney Allografts With or Without Tubulointerstitial Fibrosis (2012) (106)
Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract (2018) (100)
Noninvasive Prediction of Organ Graft Rejection and Outcome Using Gene Expression Patterns (2008) (99)
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts1 (2003) (98)
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. (2003) (93)
Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection (2019) (92)
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine1 (2002) (90)
Systemic Transforming Growth Factor-&bgr;1 Gene Therapy Induces Foxp3+ Regulatory Cells, Restores Self-Tolerance, and Facilitates Regeneration Of Beta Cell Function in Overtly Diabetic Nonobese Diabetic Mice (2005) (88)
Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients (1998) (85)
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts (2003) (85)
Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. (2007) (82)
Cyclosporine A induced remission of relapsing nephrotic syndrome in children. (1987) (78)
Noninvasive diagnosis of acute rejection of renal allografts (2010) (76)
Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. (1997) (73)
Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center (2020) (71)
Validation of Noninvasive Diagnosis of BK Virus Nephropathy and Identification of Prognostic Biomarkers (2010) (68)
Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. (1995) (62)
Messenger RNA for FOXP 3 in the Urine of Renal-Allograft Recipients (2005) (62)
Genomic biomarkers correlate with HLA-identical renal transplant tolerance. (2013) (59)
Immune stimulatory properties of metalloporphyrins. (1989) (57)
Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. (2016) (56)
Design and Implementation of the International Genetics and Translational Research in Transplantation Network (2015) (56)
Urinary Cell Levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and Acute Rejection of Human Renal Allografts (2010) (56)
Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. (2003) (56)
Transforming Growth Factor β Signaling, Vascular Remodeling, and Hypertension (2006) (55)
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporine. (1990) (55)
Gut microbiota dysbiosis and diarrhea in kidney transplant recipients (2018) (54)
Circulating transforming growth factor-β1 levels and the risk for kidney disease in African-Americans (2009) (53)
Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. (1996) (53)
Intracellular Ca2+ elevation and cyclosporin A synergistically induce TGF-beta 1-mediated apoptosis in lymphocytes. (1997) (52)
Optimization of RNA yield, purity and mRNA copy number by treatment of urine cell pellets with RNAlater. (2003) (50)
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure (2015) (50)
A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection (2019) (49)
Circulating Levels of 25-Hydroxyvitamin D and Acute Cellular Rejection in Kidney Allograft Recipients (2014) (49)
Proapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic bcl-21 (2002) (48)
Exome Sequencing and Prediction of Long-Term Kidney Allograft Function (2015) (48)
Clinical application of molecular biology: a study of allograft rejection with polymerase chain reaction. (1997) (48)
Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. (2003) (45)
Immunosuppressive drug therapy. (2013) (43)
A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. (1991) (41)
Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. (2014) (41)
Concurrent Acute Cellular Rejection Is an Independent Risk Factor for Renal Allograft Failure in Patients With C4d-Positive Antibody-Mediated Rejection (2012) (41)
Prospects and applicability of molecular diagnosis of allograft rejection. (2000) (40)
Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients. (1998) (39)
TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. (1999) (38)
Enforced c-REL deficiency prolongs survival of islet allografts1 (2002) (38)
Discovery and Validation of a Molecular Signature for the Noninvasive Diagnosis of Human Renal Allograft Fibrosis (2012) (38)
Urinary cell mRNA profiles predictive of human kidney allograft status (2014) (38)
Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation. (1993) (36)
Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling (2013) (35)
Which way for drug-mediated immunosuppression? (1994) (34)
A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor- alpha/beta complex with the cluster determinant 2 antigen (1990) (34)
Mechanisms and management of acute renal allograft rejection. (1998) (34)
EXCELLENT OUTCOME WITH A CALCIUM CHANNEL BLOCKER—SUPPLEMENTED IMMUNOSUPPRESSIVE REGIMEN IN CADAVERIC RENAL TRANSPLANTATION: A POTENTIAL STRATEGY TO AVOID ANTIBODY INDUCTION PROTOCOLS (1993) (33)
Transforming growth factor beta signaling, vascular remodeling, and hypertension. (2006) (33)
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2 (1987) (32)
Lymphocyte intracellular free calcium concentration is increased in preeclampsia. (1999) (32)
Hypertension-induced organ damage in african americans: Transforming growth factor-β1 excess as a mechanism for increased prevalence (2000) (30)
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2. (1989) (30)
Measurement of Apoptosis of Intact Human Islets by Confocal Optical Sectioning and Stereologic Analysis of YO-PRO-1–Stained Islets (2005) (30)
Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. (2003) (29)
Acute rejection of renal allografts: mechanistic insights and therapeutic options. (1997) (29)
Noninvasive diagnosis of acute rejection of solid organ transplants. (2004) (29)
Diannexin Decreases Inflammatory Cell Infiltration Into the Islet Graft, Reduces &bgr;-Cell Apoptosis, and Improves Early Graft Function (2010) (28)
normoglycemia in diabetic NOD mice (2007) (28)
The importance of genetic polymorphisms in renal transplantation. (2000) (28)
IN VIVO EXPRESSION OF TRANSFORMING GROWTH FACTOR-β1 IN HUMANS (1998) (27)
Hyperexpression of Foxp3 and IDO During Acute Rejection of Islet Allografts (2007) (27)
Butyrate‐producing gut bacteria and viral infections in kidney transplant recipients: A pilot study (2019) (27)
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. (1991) (26)
Transplantation tolerance: fooling mother nature. (1996) (26)
Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts. (2019) (25)
Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals. (1984) (25)
The natural history, risk factors and outcomes of polyomavirus BK-associated nephropathy after renal transplantation (2006) (24)
Impact of Renal Donation (1985) (24)
Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center. (2020) (24)
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. (2009) (24)
T-cell differentiation antigen cluster 2 (CD2) is a receptor for accessory cells and can generate and/or transduce accessory signals. (1988) (24)
In vivo hyperexpression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine. (1997) (23)
Separating the signal from the noise in metagenomic cell-free DNA sequencing (2019) (23)
Immunobiology and immunopharmacology of organ allograft rejection (1995) (23)
Synergism between the CD3 antigen- and CD2 antigen-derived signals. Exploration at the level of induction of DNA-binding proteins and characterization of the inhibitory activity of cyclosporine. (1993) (22)
Transforming growth factor beta and excess burden of renal disease. (2009) (22)
Ferro-mitogens: iron-containing compounds with lymphocyte-stimulatory properties. (1991) (21)
Urine biomarkers informative of human kidney allograft rejection and tolerance. (2018) (21)
Urinary cell transcriptomics and acute rejection in human kidney allografts. (2020) (21)
Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-beta expression. (1996) (21)
Mechanism of action of cyclosporine: a new hypothesis implicating transforming growth factor-β (1995) (21)
INHIBITION OF INTERLEUKIN 2 RECEPTOR EXPRESSION IN NORMAL HUMAN T CELLS BY CYCLOSPORINE: DEMONSTRATION AT THE mRNA, PROTEIN, AND FUNCTIONAL LEVELS1,2 (1992) (20)
Molecular correlates of human renal allograft rejection. (1998) (20)
Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase (1980) (20)
Noninvasive Prognostication of Polyomavirus BK Virus–Associated Nephropathy (2013) (19)
On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. (2013) (19)
Human renal allograft rejection: molecular characterization. (1998) (18)
Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression. (1994) (18)
Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact. (1985) (18)
Regulation of Transforming Growth Factor-β1 (TGF-β1) Expression with a Novel TGF-β1 Complementary DNA (1994) (18)
Expression of Fc mu receptors by human T lymphocytes: effects of enzymes, metabolic inhibitors, and X-irradiation. (1981) (17)
Role of humoral presensitization in human renal transplant rejection (1980) (17)
Erratum: Proapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic bcl-2 (Transplantation (2002) 74: 11 (1489)) (2003) (16)
Augmentation of proliferation and generation of specific cytotoxic cells in human mixed lymphocyte culture reactions by colchicine. (1980) (16)
HIV-Infected Kidney Graft Recipients Managed With an Early Corticosteroid Withdrawal Protocol: Clinical Outcomes and Messenger RNA Profiles (2013) (16)
Immunologic monitoring of the renal transplant recipient. (1983) (16)
Immunoregulatory drugs: mechanistic basis for use in organ transplantation (1997) (16)
CD2 antigen targeting reduces intragraft expression of mRNA-encoding granzyme B and IL-10 and induces tolerance. (1996) (15)
MicroRNAs and Transplantation. (2019) (15)
Dendritic Cells With TGF-&bgr;1 and IL-2 Differentiate Naive CD4+ T Cells Into Alloantigen-Specific and Allograft Protective Foxp3+ Regulatory T Cells (2012) (15)
INDUCTION OF IMMUNE ALTERATIONS AND SUCCESSFUL RENAL TRANSPLANTATION WITH A SIMPLIFIED METHOD OF DONOR‐SPECIFIC BLOOD TRANSFUSION (1984) (14)
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2. (1988) (14)
Maternal-fetal immunity: presence of specific cellular hyporesponsiveness and humoral suppressor activity in normal pregnancy and their absence in preeclampsia. (1983) (14)
Activation of human T cells with the physiological regulator of protein kinase C. (1988) (13)
Transcriptional profiling to assess the clinical status of kidney transplants (2006) (13)
Transforming growth factor-beta 1: regulation with a TGF-beta 1 antisense oligomer. (1996) (13)
Kidney Allograft Recipients Diagnosed with Coronavirus Disease-2019: A Single Center Report (2020) (13)
Early Corticosteroid Withdrawal in Recipients of Renal Allografts: A Single-Center Report of Ethnically Diverse Recipients and Recipients of Marginal Deceased-Donor Kidneys (2012) (12)
Kidney allograft failure in the steroid‐free immunosuppression era: A matched case‐control study (2017) (12)
Delayed hyperacute rejection in recipients of kidney transplants from HLA identical sibling donors. (1979) (11)
IMMUNOSUPPRESSIVE PROPERTIES OF POLAR ORGANIC COMPOUNDS THAT INDUCE CELLULAR DIFFERENTIATION IN FRIEND ERYTHROLEUKEMIA CELLS (1982) (11)
Declining transplantability of prospective kidney transplant recipients. (1981) (11)
Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression. (2001) (11)
Effect of nifedipine on renal allograft function and survival beyond one year. (1997) (11)
Anti-Ia antibody eluted from rejected human renal allografts. (1978) (11)
Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications. (1987) (11)
Optimal modes and targets of gene therapy in transplantation (2003) (11)
Single nucleotide variant counts computed from RNA sequencing and cellular traffic into human kidney allografts (2018) (11)
HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. (2013) (10)
Renal allograft surveillance by mRNA profiling of urinary cells. (2001) (10)
Posttransplant immunologic monitoring of the renal allograft recipient. (1978) (10)
FOXP3 mRNA Profile Prognostic of Acute T Cell–mediated Rejection and Human Kidney Allograft Survival (2020) (10)
OKT3-associated adverse reactions: mechanistic basis and therapeutic options. (1989) (10)
A RANDOMIZED, PROSPECTIVE, MULTICENTER TRIAL OF T‐CELL ANTIBODY INDUCTION THERAPY IN PEDIATRIC RENAL TRANSPLANTATION.: Abstract# 1 (2000) (10)
Signaling features of T cells: implications for the regulation of the anti-allograft response. (1993) (10)
Anti-tumor properties of lymphocytes activated by the oxidizing mitogens. (1986) (9)
Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial (2018) (9)
Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status. (2021) (8)
Immunostimulatory therapy with anti-CD3 monoclonal antibodies and recombinant interleukin-2: heightened in vivo expression of mRNA encoding cytotoxic attack molecules and immunoregulatory cytokines and regression of murine renal cell carcinoma. (1997) (8)
Plasmapheresis in a patient with angioimmunoblastic lymphadenopathy: Improvement in clinical and immunologic abnormalities (1983) (8)
Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients (2019) (8)
The role of interleukin-6 in mitogenic T-cell activation: detection of interleukin-2 heteronuclear RNA by polymerase chain reaction. (1991) (8)
Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction. (1990) (8)
Sex and Kidney Transplantation: Why Can't a Woman Be More Like a Man? (2017) (7)
Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling. (2014) (7)
Detection of anti-donor "Ia" antibodies: a strong correlate of rejection. (1978) (7)
Oxidative mitogenesis: participation of CD2 antigen in the generation and/or transduction of obligatory accessory signals. (1988) (7)
DIFFERENTIAL ANTIBODY RESPONSES TO Ag‐B (A REGION) AND Ia (B REGION) ANTIGENS DURING ENHANCEMENT OF RAT RENAL ALLOGRAFTS1 (1979) (7)
Role of humoral presenitization in human renal transplant rejection. (1980) (7)
A UNIQUE B CELL SIGNATURE ASSOCIATED WITH OPERATIONAL TOLERANCE: 207 (2008) (7)
Intragraft immune events causing vascularized organ graft rejection. (1978) (6)
Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation. (1996) (6)
A REAPPRAISAL OF THE EFFECTS OF MONOCLONAL ANTIBODIES DIRECTED AT T CELL DIFFERENTIATION ANTIGENS (1984) (6)
Therapeutic approach to organ transplantation. (1996) (6)
Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study (2021) (6)
Urine CXCL10/IP-10 Fingers Ongoing Antibody-Mediated Kidney Graft Rejection. (2015) (6)
Urinary-cell mRNA and acute kidney-transplant rejection. (2013) (6)
Presensitization to donor B-cell ("Ia") antigens is associated with early allograft failures. (1977) (6)
TRANSMEMBRANE SIGNALLING VIA THE T CELL ANTIGEN RECEPTOR HETERODIMER AND THE CD2 ANTIGEN (1989) (6)
Mean Arterial Blood Pressure While Awaiting Kidney Transplantation Is Associated With the Risk of Primary Nonfunction (2012) (6)
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. (1991) (6)
Immunologic monitoring: implications for treatment of rejection. (2000) (6)
Detection of infiltrating fibroblasts by single-cell transcriptomics in human kidney allografts (2020) (6)
TGF-b 1 DNA Polymorphisms , Protein Levels , and Blood Pressure (1999) (6)
MOLECULAR MONITORING OF BK VIRUS REPLICATION IN RENAL ALLOGRAFT RECIPIENTS AND IDENTIFICATION OF CORTICOSTEROID MAINTENANCE THERAPY AS AN INDEPENDENT RISK FACTOR (2004) (5)
LONG‐TERM RENAL ALLOGRAFT SURVIVAL IN RATS PREIMMUNIZED WITH DONOR STRAIN RT1.B ANTIGENS (1983) (5)
HUMAN MEMORY T CELL ACTIVATION EFFECTS OF MONOCLONAL ANTIBODIES DIRECTED AT INTERLEUKIN‐2, RECEPTORS FOR INTERLEUKIN‐2, OR INTERFERON‐γ (1988) (5)
Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens. (1978) (5)
Natural history of cadaveric kidney transplants in the absence of early acute rejection. (1983) (5)
Inhibitory activity of cyclosporine is dependent on the activating signal(s) provided to T cells. (1987) (5)
Demonstration of a direct inhibitory effect of cyclosporine on normal human T-cells with two novel models of T-cell activation as probes. (1989) (5)
Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens. (2016) (4)
Evidence for close association between B-cell Fc receptors and Ia antigens, and independence from HLA-A,B locus-determined antigens. (1977) (4)
Immunosuppressive properties of placental-source gamma globulin: results of a 5-year clinical investigative study in a cadaver kidney transplant program. (1979) (4)
Regulation of transforming growth factor-beta 1 (TGF-beta 1) expression with a novel TGF-beta 1 complementary DNA. (1994) (4)
Kidney transplantation; use of gamma globulin as an immunosuppressive agent. (1980) (4)
The prophylactic use of monoclonal antibodies in renal transplantation: a consensus conference sponsored by the American Society of Transplant Physicians. (1989) (4)
Plasmapheresis in the prevention and treatment of rapidly progressive renal disease. (1981) (4)
Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts (2020) (4)
Biological effects of activation of human peripheral blood mononuclear cells by mitogenic oxidizing agents. I Alloantigen-independent activation of alloimmune memory cells. (1981) (4)
Immunologic monitoring in the diagnosis of renal allograft rejection. (1977) (4)
A metagenomic DNA sequencing assay that is robust against environmental DNA contamination (2021) (4)
Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions. (1987) (4)
IDENTIFICATION OF HUMAN LYMPHOCYTE SUBPOPULATIONS BY RAPID MICROROSETTE TECHNIQUE (1977) (4)
ENHANCED KIDNEY GRAFT SURVIVAL WITH RETROPLACENTAL SOURCE γ‐GLOBULIN: RESULTS OF A 5‐YEAR PROSPECTIVE STUDY AT A SINGLE CENTER (1982) (4)
Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing Assays (2021) (4)
Modulation of mouse mesangial cell proliferation by thiourea and lipoxygenase inhibitors. (1994) (4)
Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays. (1979) (3)
Transplantation: Pump it up: conserving a precious resource? (2009) (3)
IN VITRO MODULATION OF PHYTOHEMAGGLUTININ-P INDUCED BLASTOGENESIS BY PARATHYROID HORMONE (1977) (3)
Taking stock and moving forward (2003) (3)
Chronic reduction of store operated Ca2+ entry is viable therapeutically but is associated with cardiovascular complications (2022) (3)
T-cell antigen recognition and costimulatory pathways: implications for the induction of transplantation tolerance. (2000) (3)
Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion. (1985) (3)
Dendritic Cells Armed With Anti-CD3 mAbs Reduce Pulmonary Metastases, Prolong Survival, and Engender Antitumor Effector Cells Demonstrable by Adoptive Transfer (2000) (3)
Transmembrane signaling requirements of T cells: implications for regulation of alloimmunity. (1995) (3)
Regulation of the anti-allograft response by targeting the CD2 antigen: a potential strategy for the creation of transplant tolerance. (1996) (2)
Signaling via the T-cell antigen receptor heterodimer and the CD2 antigen: a novel, synergistic pathway for activation of T-cells. (1989) (2)
Kidney Allograft Function Is a Confounder of Urine Metabolite Profiles in Kidney Allograft Recipients (2021) (2)
IDENTIFICATION OF FUNCTIONAL GENE CLUSTERS FOR CHRONIC ALLOGRAFT NEPHROPATHY BY HIGH DENSITY OLIGONUCLEOTIDE MICROARRAY PROFILING. (2004) (2)
Validation of a noninvasive prognostic signature for allograft failure following BK virus associated nephropathy (2020) (2)
Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression. (1994) (2)
Human renal allograft rejection: Immune mechanisms, molecular correlates and treatment strategies (1996) (2)
Transplantation: Personalizing induction therapy in kidney transplantation (2009) (2)
215.10: Tolerant Kidney Transplant Recipients Display a Unique CTLA-4 Dominant Urinary Cell mRNA Signature (2022) (2)
Urinary cell mRNA profiling of kidney allograft recipients: A systematic investigation of a filtration based protocol for the simplification of urine processing. (2021) (2)
Two-signal model for T-cell activation: molecular mechanisms. (1993) (2)
The advantage of measurement of intact PTH in the prediction of clinical response and calcium metabolism after subtotal parathyroidectomy for renal osteodystrophy. (1983) (2)
Urinary cell mRNA profiling of kidney allograft recipients: Development of a portable protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy (2022) (2)
Intrarenal display of cytotoxic attack molecules during rejection. (1997) (2)
MOLECULAR QUIESCENCE, DESPITE MINIMAL IMMUNOSUPPRESSIVE THERAPY, IS THE CHARACTERISTIC PROFILE OF RENAL ALLOGRAFT RECIPIENTS WITH MORE THAN 2-DECADES OF ALLOGRAFT FUNCTION. (2004) (2)
Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children (2021) (2)
A metagenomic DNA sequencing assay that is robust against environmental DNA contamination (2022) (2)
Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction. (2012) (2)
The Immune Response to Organ Allografts (2009) (2)
Foxp3+ regulatory cells in urine: A biomarker of renal allograft rejection outcome (2005) (1)
Generation of specific secondary cytotoxic T cells by treatment of long-term primary MLC cells with sodium periodate. (1979) (1)
Alloantigen-independent activation of alloimmune memory cells by soluble factors from mitogen-primed cells. (1981) (1)
ABROGATION OF PROLIFERATION AND GENERATION OF CYTOTOXIC T CELLS IN HUMAN MIXED LYMPHOCYTE CULTURE REACTIONS BY MODIFICATION OF THE CELL SURFACE WITH MITOGENIC OXIDIZING AGENTS (1982) (1)
Presumed assault or accommodative reactions involved in human renal transplantation. (1984) (1)
T-Cell-Positive, B-Cell-Negative Flow Cytometry Crossmatch: Frequency, HLA Locus Specificity, and Mechanisms Among 3073 Clinical Flow Cytometry Crossmatch Tests. (2022) (1)
Enhanced kidney-graft survival with retroplacental-source gamma globulin: Results of a five year prospective study at a single center (1982) (1)
Biomarkers of allograft rejection and tolerance (2015) (1)
INTRARENAL EXPRESSION OF CYTOTOXIC ATTACK MOLECULES DURING ACUTE REJECTION OF RENAL ALLOGRAFTS IN PEDIATRIC RECIPIENTS (1998) (1)
Should hepatitis C virus infection be a contraindication to renal transplantation? (2008) (1)
DIFFERENTIAL EXPRESSION OF BMP-7, TGFA1 AND GRANZYME B DURING ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS: A PLAUSIBLE MOLECULAR LINK BETWEEN ACUTE REJECTION AND CHRONIC ALLOGRAFT INJURY: 880 (2008) (1)
Periodate and recombinant interleukin-2-activated autologous leukocytes can induce regression of metastases of renal cancer. (1988) (1)
Pretransplant assays of alloimmunity in predicting renal graft outcome. (1977) (1)
Urinary cell mRNA Profiling of Kidney Allograft Recipients: A Systematic Investigation of a Filtration Based Protocol for the Simplification of Urine Processing (2021) (1)
A NOVEL IMMUNOREGULATORY ROLE FOR ANTI-CD3 mAbs: DENDRITIC CELLS, PULSED WITH TUMOR CELLS AND ARMED WITH ANTI-CD3 mAbs, ARE HIGHLY EFFECTIVE IN CONSTRAINING TUMOR PROGRESSION. (1999) (1)
Quantitative competitive polymerase chain reaction: design and synthesis of mRNA-specific competitor DNA templates and their clinical usage. (1998) (1)
Adaptive Immune Landscape of T-Cell Mediated Rejection of Human Kidney Allografts (2022) (1)
Exome Sequencing, Histoincompatibility and Long-Term Kidney Allograft Function (2015) (1)
DENDRITIC CELL CONDITIONING WITH CYCLOSPORINE: CONVERSION FROM AN IMMUNIZING TO A TOLEROGENIC PHENOTYPE. (1999) (1)
MICRORNA EXPRESSION SIGNATURES DISTINGUISH HUMAN RENAL ALLOGRAFTS WITH INTERSTITIAL FIBROSIS/TUBULAR ATROPHY FROM NORMAL: 1051 (2010) (1)
TRANSFORMING GROWTH FACTOR-β INDUCIBLE GENE-h3 (βig-h3) mRNA EXPRESSION CORRELATES WITH TGF-β1 mRNA HYPEREXPRESSION IN HUMAN RENAL ALLOGRAFTS. (1999) (1)
Signaling normal human T-cells: synergism between CD2 antigen and CD3/T cell receptor alpha beta complex in the elicitation of IL-2 and IL-2 receptor gene expression. (1991) (1)
54-OR: On The Monitoring of Donor Specific Antibodies Using Solid Phase Assays: Existing Challenges (2010) (1)
20-OR: Failure to delete CD19+CD27+ memory B cells by Rituximab in sensitized renal allograft recipients (2007) (1)
Rituximab Therapy Decreases Acute Rejection Rates Among Sensitized Renal Allograft Recipients: 431 (2008) (1)
Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract (2018) (1)
Renal transplantation: reaping the rewards of biomedical research (2000) (1)
Immunological properties of subcellular rat lymphocyte preparations. Primary allogeneic stimulation in vitro by fractions containing Ia (RT1- B), but not RT1-A antigens (1980) (1)
Single Nucleotide Polymorphisms in Promoter Region of Tgf-β1 Gene Distinguish African Americans from Caucasians: A Possible Genetic Basis for Racial Differences in Epidemiology of Hypertension and End Stage Renal Disease. (2000) (1)
Optimization of donor specific blood transfusion in kidney transplantation. (1987) (1)
HLA-D activity in lymphocyte subcellular fractions. (1978) (1)
Induce cellular differentiation in friend erythroleukemia cells. (1982) (1)
IN VIVO EFFECTS OF HIGH‐DOSE STEROIDS ON NUCLEIC ACID CONTENT OF IMMUNOCOMPETENT CELLS OF RENAL ALLOGRAFT RECIPIENTS (1988) (1)
Altered nucleic acid contents of mononuclear cells in blood of renal allograft recipients. (1988) (1)
IN VITRO STIMULATION OF UNPRIMED LYMPHOCYTES BY ALLOGENEIC SEMI-SOLUBLE LYMPHOCYTE MEMBRANE FRAGMENTS (1977) (1)
Regulation of human mixed lymphocyte culture reactions: augmentation of proliferation and generation of cytotoxic cells. (1978) (1)
51-P: Exceptional HLA-DR16 without DR51 (DRB5*) haplotypes found during molecular HLA typing for solid-organ transplantation (2009) (1)
QUANTIFICATION OF CYTOTOXIC GENES IN URINARY CELLS: NOVEL BIOMOLECULAR MARKERS OF ACUTE RENAL ALLOGRAFT REJECTION.: Abstract# 1029 (2000) (1)
Adverse presensitization: detection by utilization of B lymphoblastoid cell panels. (1979) (1)
SYSTEMIC TGF-BETA1 GENE THERAPY INDUCES CD4+CD25+ FOXP3+ REGULATORY T CELLS, RESTORES SELF-TOLERANCE AND FACILITATES ISLET REGENERATION IN OVERTLY DIABETIC NOD MICE (2004) (1)
Separating the signal from the noise in metagenomic cell-free DNA sequencing (2020) (1)
OR17 Epitope load does not predict development of de novo antibodies to HLA in patients with BK virus nephropathy (2018) (1)
Involvement of tumor necrosis factor in development of anti-CD3 monoclonal antibody induced pulmonary edema. (1994) (0)
Prognostication of Bkv Nephritis Using Gene Expression Patterns and Development of a Combination Regimen of Ivig, Leflunomide and Reduced Tacrolimus (Ilrt) to Optimize Outcome: 226 (2008) (0)
Transplantation: A Report of Progress (2005) (0)
DIFFERENTIAL REGULATION OF POSITIVE OR NEGATIVE COSTIMULATORY MOLECULES DURING ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS: 1025 (2010) (0)
1-P: Solid-phase (SP) HLA antibody identification (AbID), mean fluorescence intensity (MFI) and the complement dependent cytotoxicity cross-match (CDC XM) result (2009) (0)
P024 : POTENTIAL FOR A FALSE POSITIVE B CELL FLOW CYTOMETRY CROSSMATCH WITH THE USE OF FLUORESCEIN ISOTHYOCYANATE-GOAT-ANTI-HUMAN IMMUNOGLOBULIN-G ANTIBODY (2014) (0)
Host-pathogen interactions in urinary tract infection from the structure and diversity of urinary cell-free DNA (2017) (0)
Generation of a lymphocyte growth factor by cells activated by mitogen oxidizing agents (1980) (0)
The Nobel Prize-winning work of Ralph Steinman (1943-2011) and its relevance to transplantation. (2013) (0)
A new class of immunosuppressants: Agents that induce erythroid differentiation in Friend leukemia cells inhibit transplant immune responses (1982) (0)
DEVELOPMENT OF URINE RT-QUANTITATIVE-PCR FOR THE MOLECULAR DIAGNOSIS OF ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS (1999) (0)
Molecular Characterization of Rejection in Solid Organ Transplantation (2006) (0)
A cell-free DNA metagenomic sequencing assay that integrates the damage response to infection (2019) (0)
Transplantation: a report of progress. (2008) (0)
MHC‐INDEPENDENT ALLOGRAFT VASCULAR DISEASE: mRNA EXPRESSION PROFILE IN A MHC CONGENIC RAT HETEROTOPIC CARDIAC TRANSPLANTATION MODEL.: Abstract# 721 (2000) (0)
A tribute to Terry Strom. (2018) (0)
Transmembrane signaling requirements of T cells. (1993) (0)
P133 A reappraisal of the impact of heat inactivation of kidney graft recipient’s serum on donor T cell and B cell CDC crossmatches: An analysis of 22175 consecutive crossmatches performed by a single histocompatibility laboratory (2018) (0)
WELCOME TO A NEW TRANSPLANTATION JOURNAL (2000) (0)
Role of HLA DR in renal transplantation. (1982) (0)
A new class of immunosuppressants: Agents that induce erythroid differentiation in Friend leukemia cells inhibit cellular and humoral immune responses (1983) (0)
PREDCT THE OUTCOME OF ORGANS UNDERGOING ACUTE REUECTION (2017) (0)
A High Throughput Molecular Assay for Detection of Renal Graft Acute Cellular Rejection Using Peripheral Blood (2012) (0)
IMMUNITY, INFLAMMATION AND REMODELING: MOLECULAR EVIDENCE FOR CONCURRENCE IN HUMAN RENAL ALLOGRAFTS (1999) (0)
PARADIGM LOST: IL-10 IS A SUPERIOR CORRELATE OF ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS COMPARED TO TH1 CYTOKINE IFN-γ. (1998) (0)
MRNA PROFILES OF URINARY CELLS DISTINGUISH ALLOGRAFT INFILTRATES ASSOCIATED WITH ACUTE REJECTION FROM INFILTRATES THAT DO NOT CAUSE PROXIMATE ACUTE REJECTION. (2004) (0)
Noninvasive Diagnosis of Acute Antibody Mediated Rejection of Human Kidney Transplant Recipients by Measurement of Serum MicroRNAs: 2104 (2012) (0)
P143 Development and validation of LSAB MFI cutpoints for use in the virtual crossmatch test to predict flow cytometry crossmatch (FCXM) and cdc crossmatch (CDC XM) results (2018) (0)
DETECTION OF ALLOIMMUNE MEMORY CELLS BY CHEMICAL MODIFICATION OF THE CELL SURFACE WITH MITOGENIC OXIDIZING AGENTS (1980) (0)
Gene-Expression Profiles of Peripheral Blood Cells and of Allograft Biopsies Are Associated With Acute Rejection in Pediatric Renal Allograft Recipients.: Abstract# C1528 (2014) (0)
Whole Blood mRNA to Detect Hepatic Inflammation and Fibrosis in Post-Liver Transplant Patients With HCV.: Abstract# D2356 (2014) (0)
NON-INVASIVE MOLECULAR DIAGNOSIS OF ACUTE REJECTION OF RENAL ALLOGRAFTS: BETA-2-MICROGLOBULIN (β2m) mRNA IS HYPEREXPRESSED IN PERIPHERAL BLOOD MONONUCLEAR CELLS OBTAINED FROM PATIENTS WITH ACUTE REJECTION. (1999) (0)
Renal transplantation - clinical studies - 2 (2009) (0)
P233 On the performance characteristics of luminex single antigen bead (LSAB) assay mean fluorescence intensity cutpoint in predicting flow cytometry crossmatch (FCXM) results (2017) (0)
Dual transplantation of kidneys from expanded criteria donors: maximizing the use of a scarce resource (2007) (0)
Structure and diversity of urinary cell-free DNA informative of host-pathogen interactions in human urinary tract infection (2018) (0)
35-OR: Rituximab prophylaxis reduces acute rejection risk in pre-sensitized renal allograft recipients (2007) (0)
Detection of memory cells by chemical modification of the lymphocyte cell surface. (1979) (0)
Renal transplantation - clinical studies - 3 (2009) (0)
Chronic Allograft Nephropathy Is Associated With Reduced Expression of Foxp3: 2221 (2008) (0)
Single-Cell Transcriptomics of Human Native Kidney and Kidney Allografts and New Insights Into the Mechanism of Fibrosis (2020) (0)
Single-Cell Transcriptomics of Human Native Kidney and Kidney Allografts and New Insights Into the Mechanism of Fibrosis (2020) (0)
Monday, June 28, 2010: Free Communications (2010) (0)
DNA sequencing based biophysical characterization of cell-free DNA in the blood circulation sheds light on its origin (2018) (0)
Cell cycle analysis of activated mononuclear blood cells of renal allograft recipients. (1987) (0)
Faculty Opinions recommendation of Long-Term Survival after Kidney Transplantation. (2021) (0)
87 DENDRITIC CELL-DEPENDENT INDUCTION OF BETA CELL-SPECIFIC REGULATORY T CELLS FOR SUPPRESSION OF AUTOIMMUNE DIABETES. (2007) (0)
Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents. (1981) (0)
P023 : TAGGING CELLS IN FLOW CYTOMETRY CROSSMATCH: PLATE METHOD PROVIDES HIGHER B CELL PERCENTAGE AS COMPARED TO TUBE METHOD (2014) (0)
Fecal Microbiota Community Structure and Kidney Transplantation Outcomes: A Pilot Study.: Abstract# 2204 (2014) (0)
Unique and Shared Molecular Pathways Driving Acute T-Cell Mediated Rejection or Acute Antibody Mediated Rejection of Human Kidney Allografts Unmasked by Urinary Cell mRNA Profiling: 2214 (2012) (0)
Human gamma globulin enhances the survival of renal allografts. (1979) (0)
ANGIOTENSIN II RECEPTOR BLOCKADE: A NOVEL STRATEGY TO PREVENT IMMUNOSUPPRESSANT ASSOCIATED CANCER PROGRESSION.: Abstract# 1075 (2000) (0)
51-P: NEGATIVE HLA DSA BY LUMINEX SOLID PHASE ASSAY AND POSITIVE DONOR CDC CROSSMATCH: A CROSSMATCH CONUNDRUM (2012) (0)
URINARY CELL mRNA PROFILES ACCURATELY PREDICT RENAL ALLOGRAFT INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY: 39 (2008) (0)
55-P Molecular size exclusion using membrane filters is effective for correcting the abnormal MFI that confound DSA interpretation (2011) (0)
Helping cell-free DNA sequencing become a better diagnostic tool in the clinic (2020) (0)
Activation of alloimmune memory cells by soluble factors: a model for elicitation of specific allograft responses by immunologically nonspecific signals. (1980) (0)
TRAFFICKING OF FOXP3+ REGULATORY CELLS IN TO HUMAN RENAL ALLOGRAFTS AND REGULATION OF ANTI-ALLOGRAFT IMMUNITY. (2004) (0)
URINARY GENE EXPRESSION PROFILE IN THE EARLY POST-TRANSPLANT PERIOD IS PREDICTIVE OF LONG-TERM RENAL ALLOGRAFT FUNCTION. (2006) (0)
P086 MFI, MFI everywhere: Is there a clinically applicable MFI cutpoint anywhere? (2017) (0)
P8.012: The Impact of a Positive B-Cell Flow Crossmatch in Living Donor Renal Transplant Recipients (2022) (0)
Deep sequencing of DNA from urine of kidney allograft recipients to estimate the donor-specific DNA fraction (2020) (0)
DENDRITIC CELLS PLUS TGF-BETA1 DIFFERENTIATED NAÏVE CD4+ T CELLS BUT NOT NATURAL REGULATORY T CELLS PROTECT ALLOGRAFTS: 510 (2008) (0)
Adoptive Immunotherapy for Renal Adenocarcinoma: Use of Oxidizing Mitogen-Treated Mononuclear Leukocytes and Continuous Infusion of Interleukin-2 (1990) (0)
Deep Sequencing of Human Renal Allografts and Discovery of MicroRNA Signatures of Allograft Fibrosis: 2267 (2012) (0)
Analysis of spontaneous blastogenesis profiles in recipients of renal allografts. (1989) (0)
Chapter 49 – Transplantation (2005) (0)
319 Optimizing Urinary cell mRNA profiling of kidney allograft recipients: Development of a home processing protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy (2023) (0)
BKV replication and acute rejection: Does one trigger the other? (2005) (0)
DEVELOPMENT OF A NOVEL RETROVIRAL VECTOR BASED IL2 GENE THERAPY: DEMONSTRATION OF EFFICACY IN A RENAL CELL CARCINOMA MODEL (1999) (0)
A Quantitative Evaluation of Immune Activation Cytokine Gene Transcripts in Renal AllograftBiopsies 1842 (1998) (0)
206-P On HLA DNA typing by SSOP: Investigation of QC parameters and DNA requirement for accurate allele discrimination (2011) (0)
SYSTEMIC TGF-BETA1 GENE THERAPY INDUCES FOXP3+ REGULATORY T CELLS AND DELAYS THE DEVELOPMENT OF AUTOIMMUNE DIABETES IN NONOBESE DIABETIC MICE: 1038 (2010) (0)
Immunology, sensitization, and histocompatibility (2015) (0)
HYPOEXPRESSION OF GRANZYME B AND TRANSFORMING GROWTH FACTOR BETA-1 DESPITE MINIMAL IMMUNOSUPPRESSIVE THERAPY. (2006) (0)
Transplantation tolerance: Fooling (2016) (0)
D lucus antigen defined lymphoblastoid cell panel allows detection of hitherto undetected adverse presensitization. (1978) (0)
Monoclonal antibodies to human fetal hemoglobin. Abstr. (1981) (0)
FOXP3 mRNA profile prognostic of T cell mediated rejection and human kidney allograft survival (2020) (0)
Conferences of the Mario Negri Institute ( Bergamo ) Nephrology Dialysis Transplantation Therapeutic approach to organ transplantation (2005) (0)
Human T Cell Activation: Participation of T Cell Differentiation Antigen Cluster 2 (CD2) in the Generation and/or Transduction of Accessory Cell Signals (1988) (0)
167-P: Improvement in Proteinuria After Bortezomib-Based Therapy in a Patient With Transplant Glomerulopathy (2010) (0)
Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment. (1994) (0)
Enhancing laboratory safety without compromising diagnostic accuracy (2005) (0)
Urine as liquid gold: the transcriptional landscape of acute rejection defined by urinary cell mRNA profiling of kidney allograft recipients (2023) (0)
Activation of T cells via cell-cell interaction: role of growth factors and accessory cells. (1984) (0)
217-P A case of mistaken identity: HAMAs resulting in a false positive B cell flowcytometry crossmatch (2011) (0)
T Cell Positive B Cell Negative Flow Cytometry Crossmatch (FCXM): Frequency, HLA-Locus Specificity, and Mechanisms Among 3073 Clinical FCXM Tests (2021) (0)
Concomitant ACR: A Novel Predictor of Allograft Failure in Patients with Acute Antibody-Mediated Rejection of Renal Allograft: 1974 (2012) (0)
Urinary Cell mRNA Profiles Demonstrate Persistent BKV Replication and a Profibrotic Milieu Despite Clearance of BK Viremia/Nephropathy.: Abstract# D2354 (2014) (0)
Induction of suppressor cell activity by concanavalin a (Con A) in the absence of DNA synthesis (1980) (0)
Cellular and humoral mechanisms in the pathogenesis of tubulointerstitial nephritis. (1985) (0)
DEVELOPMENT OF A NEW STRATEGY FOR MINIMIZING ISLET CELL MASS IN TYPE 1 DIABETIC RECIPIENTS: DIANNEXIN REDUCES PROAPOPTOTIC BID, PROMOTES ANTI-INFLAMMATORY INTERLEUKIN-10 AND IMPROVES EARLY GRAFT FUNCTION IN THE MARGINAL ISLET MASS TRANSPLANTATION MODEL: 331 (2010) (0)
Increased expression of CD40, B7–2, interleukin-15 and granzyme B in bronchoalveolar lavage cells from human lung transplant recipients (2003) (0)
13-P: Profiling of HLA antibodies in wait listed organ graft recipients with the use of solid phase single antigen beads: Pre-sensitization to class I and II and implications for the calculated PRA (CPRA) (2009) (0)
Development of a Bak gene based standard curve for absolute quantification of BK virus in real time quantitative PCR assay and noninvasive diagnosis of BK virus nephropathy in kidney allograft recipients. (2022) (0)
Deep sequencing of DNA from urine of kidney allograft recipients to estimate donor/recipient-specific DNA fractions (2021) (0)
DRIED BLOOD SPOT MEASUREMENT OF TACROLIMUS IS SUITABLE FOR PATIENT MONITORING (2006) (0)
Immunosurveillance mechanisms operative in renal allograft recipients (1983) (0)
MHC-independent allograft vascular disease: mRNA profile in the MHC congenic rat heterotopic cardiac transplant model. (2001) (0)
PERIPHERAL BLOOD CELL MESSENGER RNA PROFILES DIAGNOSTIC OF ACUTE REJECTION OF ALLOGRAFTS (2010) (0)
Methods of evaluation of replacement of transplantation. (1998) (0)
Faculty Opinions recommendation of PIRs mediate innate myeloid cell memory to nonself MHC molecules. (0)
Evolution of immunosuppressive treatment modalities for renal transplant recipients. (1984) (0)
The Medawar Prize Acceptance Speech 2022. (2022) (0)
Transplantation: A Report of Progress (2006) (0)
Selective modulation of gene expression in activated normal human peripheral blood mononuclear cells by store-operated calcium entry blocker BTP2 (2023) (0)
HYPEREXPRESSION OF CTLA-4 mRNA DURING ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS. (2006) (0)
PROGNOSTICATORS OF KIDNEY ALLOGRAFT OUTCOME FOLLOWING ACUTE ANTIBODY-MEDIATED REJECTION: A SINGLE CENTER EXPERIENCE: 2490 (2010) (0)
URINARY CELL MESSENGER RNA PROFILES PREDICT ALLOGRAFT OUTCOME IN PATIENTS WITH BKV NEPHROPATHY (2004) (0)
50-P: THE SURVEY: UTILIZING LOW RESOLUTION TYPING TO PREDICT HIGH RESOLUTION TYPING – A VIRTUAL TOOL (2012) (0)
P161 Kidney allograft outcomes associated with locus specific IgG antibodies to donor class I (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Manikkam Suthanthiran?

Manikkam Suthanthiran is affiliated with the following schools:

Manikkam Suthanthiran's Academic­Influence.com Rankings

Manikkam Suthanthiran's Degrees

Why Is Manikkam Suthanthiran Influential?

Manikkam Suthanthiran's Published Works

Published Works

What Schools Are Affiliated With Manikkam Suthanthiran?

Manikkam Suthanthiran's AcademicInfluence.com Rankings